Report of Foreign Issuer (6-k)
April 04 2017 - 6:05AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
For the month of
April
Commission File Number 001-37518
Benitec
Biopharma Limited
(Translation of registrant’s name into English)
Suite 1201,
99 Mount Street, North Sydney NSW 2060 AUSTRALIA
(Address of principal
executive office)
Indicate by check mark whether the registrant files or will
file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F
x
Form 40-F
¨
Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
¨
Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
¨
Indicate by check mark whether the registrant by furnishing
the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b)
under the Securities Exchange Act of 1934.
Yes
¨
No
x
If “Yes” is marked, indicate below the file number
assigned to the registrant in connection with Rule 12g3-2(b): n/a
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.
|
Benitec Biopharma Limited
|
|
|
|
|
|
|
Date:
4/3/2017
|
By:
|
/s/ GREG WEST
|
|
Name:
|
Greg West
|
|
Title:
|
Company Secretary
|
EXHIBIT INDEX
Exhibit
Number
|
|
Description
|
99.1
|
|
OPMD KEY DATA PUBLISHED IN NATURE
|
Benitec Biopharma (NASDAQ:BNTC)
Historical Stock Chart
From Sep 2024 to Oct 2024
Benitec Biopharma (NASDAQ:BNTC)
Historical Stock Chart
From Oct 2023 to Oct 2024